文献速递中枢神经肿瘤放疗放疗物理与技术

脑转移瘤血肿瘤屏障开放从放疗前到放疗后一个月的变化

Blood-tumor barrier opening changes in brain metastases from pre to one-month post radiation therapy.
PubMed 文献 · Radiother Oncol · 2017-08-20

该研究纳入30例接受全脑放疗或立体定向放射外科的脑转移瘤患者,共分析64个病灶,用动态对比增强MRI定量Ktrans评估血肿瘤屏障开放程度与时间进程。结果显示高渗透性病灶放疗后%Vall无显著下降,低渗透性病灶%Vall显著升高(p=0.01),提示放疗后2-4周可能是启动全身治疗的最佳时机。

要点

  • 高渗透性病灶放疗后%Vall由85.4%降至76.9%,变化无统计学显著性。
  • 低渗透性病灶%Vall由5.6%升至1-2周30.2%、1个月52.6%(p=0.01)。
  • 放疗后2-4周血肿瘤屏障开放程度较高,或为全身治疗较优启动时机。

核心结论

  • 初步结果表明放疗后2-4周低渗透性与高渗透性脑转移灶血肿瘤屏障开放均较高,可能是启动全身治疗的最佳时机。

研究设计与样本

  • 研究纳入30例接受全脑放疗或立体定向放射外科的脑转移瘤患者,共分析64个转移灶。
  • 采用动态对比增强MRI定量转运常数Ktrans,于放疗前、放疗开始后1-2周及放疗后1个月采集。
  • 按放疗前Ktrans>0.005min-1的病灶体积百分比(%Vall)是否大于50%将病灶分为高渗透性与低渗透性。

主要发现

  • 6例患者同时存在低渗透性(n=7)与高渗透性(n=10)病灶,观察到患者内与病灶间异质性。
  • 基线病灶渗透性显示显著的病灶大小效应。
  • 高渗透性病灶接受全脑放疗(n=43)或立体定向放射外科(n=14)后%Vall由放疗前85.4%降至放疗后1个月76.9%,变化无统计学显著性。
  • 低渗透性病灶(n=7,均接受全脑放疗)%Vall由放疗前5.6%升至放疗开始后1-2周30.2%、放疗后1个月52.6%(p=0.01)。

关键数值与推荐

  • 以放疗前Ktrans>0.005min-1的病灶体积百分比(%Vall)大于50%定义为高渗透性,小于50%定义为低渗透性。
  • 低渗透性病灶%Vall从放疗前5.6%升至放疗开始后1-2周30.2%及放疗后1个月52.6%,p=0.01。

临床怎么用

  • 对脑转移瘤患者,可参考放疗后2-4周血肿瘤屏障开放较高的时间窗来安排全身治疗。
  • 评估血肿瘤屏障开放时需注意患者内与病灶间异质性及病灶大小对基线渗透性的影响。

局限性

  • 作者称结果为初步结果。
  • 低渗透性病灶样本量小(n=7)且均接受全脑放疗。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: Blood-tumor barrier is a limiting factor for effectiveness of systemic therapy to brain metastases. This study aimed to assess the extent and time course of BTB opening in BM following whole-brain radiotherapy (WBRT) or stereotactic radiosurgery (SRS) to determine optimal timing for systemic therapy. MATERIALS AND METHOD: 30 patients received WBRT or SRS and a total of 64 metastatic lesions were analyzed. Dynamic contrast-enhanced MRI were acquired, to quantify a transfer constant (Ktrans), pre-RT, 1-2weeks after starting RT (Wk1-2), and 1-month post-RT (1M post-RT). Lesions were categorized as either low or high permeability based upon the pre-RT percentage volume of a lesion with Ktrans>0.005min-1 (%Vall) less or greater than 50%. Time-course changes of %Vall after RT were analyzed. RESULTS: Fifty-seven lesions had high-permeability and seven had low-permeability at baseline. Intra-patient and inter-lesion heterogeneity was observed in six patients who had both low- (n=7) and high-permeability lesions (n=10). Also, lesion permeability showed a significant size-effect at baseline. For high-permeability lesions, either received WBRT (n=43) or SRS (n=14), %Vall decreased non-significantly following RT (from 85.4% pre-RT to 76.9% 1M post-RT). For low-permeability lesions (n=7, all received WBRT), %Vall increased from 5.6% pre-RT to 30.2% at Wk1-2 and to 52.6% 1M-post (p=0.01). CONCLUSION: Our preliminary results suggest that 2-4weeks after RT, when BTB opening is high for both low- and high-permeability brain metastatic lesions, could be optimal time to start systemic therapy.

来源:Radiother Oncol,查看原文。版权归原作者所有。

引用

  1. Teng F, Tsien CI, Lawrence TS, et al. Blood-tumor barrier opening changes in brain metastases from pre to one-month post radiation therapy. Radiother Oncol. 2017. PMID: 28835339. doi:10.1016/j.radonc.2017.08.006

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。